Mitochondrial Oxidative Stress and Mitochondrial DNA
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378849433 | ||
| 003 | CHVBK | ||
| 005 | 20180305123319.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20030919xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/CCLM.2003.195 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2003.195 | ||
| 245 | 0 | 0 | |a Mitochondrial Oxidative Stress and Mitochondrial DNA |h [Elektronische Daten] |c [Dongchon Kang, Naotaka Hamasaki] |
| 520 | 3 | |a Mitochondria produce reactive oxygen species (ROS) under physiological conditions in association with activity of the respiratory chain in aerobic ATP production. The production of ROS is essentially a function of O2 consumption. Hence, increased mitochondrial activity per se can be an oxidative stress to cells. Furthermore, production of ROS is markedly enhanced in many pathological conditions in which the respiratory chain is impaired. Because mitochondrial DNA, which is essential for execution of normal oxidative phosphorylation, is located in proximity to the ROS-generating respiratory chain, it is more oxidatively damaged than is nuclear DNA. Cumulative damage of mitochondrial DNA is implicated in the aging process and in the progression of such common diseases as diabetes, cancer, and heart failure. Clin Chem Lab Med 2003; 41(10):12811288 | |
| 540 | |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG | ||
| 690 | 7 | |a Medical equipment & techniques |2 nationallicence | |
| 690 | 7 | |a Medical diagnosis |2 nationallicence | |
| 690 | 7 | |a Diseases & disorders |2 nationallicence | |
| 700 | 1 | |a Kang |D Dongchon |4 aut | |
| 700 | 1 | |a Hamasaki |D Naotaka |4 aut | |
| 773 | 0 | |t Clinical Chemistry and Laboratory Medicine |d Walter de Gruyter |g 41/10(2003-09-19), 1281-1288 |x 1434-6621 |q 41:10<1281 |1 2003 |2 41 |o cclm | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/CCLM.2003.195 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/CCLM.2003.195 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kang |D Dongchon |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Hamasaki |D Naotaka |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Clinical Chemistry and Laboratory Medicine |d Walter de Gruyter |g 41/10(2003-09-19), 1281-1288 |x 1434-6621 |q 41:10<1281 |1 2003 |2 41 |o cclm | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||